![Kinichiro Kominami](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kinichiro Kominami
Directeur/Membre du Conseil chez
DELTA-FLY PHARMA, INC.
Fortune : 54 640 $ au 31/07/2026
Profil
Dr. Kinichiro Kominami is an Independent Outside Director at Veritas In Silico Inc., an Independent Non-Executive Outside Director at Delta-Fly Pharma, Inc., an Independent Non-Executive Outside Director at Perseus Proteomics, Inc. and a President & Representative Director at Tech & FinStrategy, Inc. He is on the Board of Directors at Veritas In Silico Inc., Delta-Fly Pharma, Inc., Perseus Proteomics, Inc. and Tech & FinStrategy, Inc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2025 | 60 000 ( 0,33% ) | 54 640 $ | 31/07/2026 |
Postes actifs de Kinichiro Kominami
| Sociétés | Poste | Début |
|---|---|---|
| DELTA-FLY PHARMA, INC. | Directeur/Membre du Conseil | 01/06/2018 |
| PERSEUS PROTEOMICS INC. | Directeur/Membre du Conseil | 01/06/2018 |
| VERITAS IN SILICO INC. | Directeur/Membre du Conseil | 01/08/2019 |
Tech & FinStrategy, Inc.
 Tech & FinStrategy, Inc. Miscellaneous Commercial ServicesCommercial Services Provides business consulting and plans preparation support services | President | 01/09/2017 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
22
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Perseus Proteomics, Inc.
 Perseus Proteomics, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets antibody-based therapeutics and diagnostics | Health Technology |
Delta-Fly Pharma, Inc.
 Delta-Fly Pharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the bio-pharmaceutical development business | Health Technology |
Veritas In Silico Inc.
 Veritas In Silico Inc. BiotechnologyHealth Technology Develops drugs against structural motifs on mRNA | Health Technology |
Tech & FinStrategy, Inc.
Tech & FinStrategy, Inc. Miscellaneous Commercial ServicesCommercial Services Provides business consulting and plans preparation support services | Commercial Services |
